Skip to content

The effect of jujube and saffron supplement on Covid-19

Investigating the effect of oral supplementation containing jujube and saffron on recovery and controlling the symptoms of patients with covid-19

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160305026917N2
Enrollment
60
Registered
2021-05-25
Start date
2021-07-21
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19. Covid-19

Interventions

Intervention 1: Intervention group: Standard treatment will be performed and a saffron-jujube supplement will be prescribed with it for 30 patients. The duration of the intervention is 2 weeks and the

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: Clinical or paraclinical confirmation of disease Absence of underlying disease including diabetes, thyroid disorders, cardiovascular, autoimmune, and hemorrhagic and other lung diseases No pregnancy and breastfeeding.

Exclusion criteria

Exclusion criteria: Patients with severe forms of the disease (patients under ventilator, patients with oxygen saturation below 88 mm Hg, and patients admitted to the ICU The patient's unwillingness to continue participating in the project Sensitivity to the components of the supplement.

Design outcomes

Primary

MeasureTime frame
Investigation of radiological changes. Timepoint: 0 (before the intervention), 7th, 14th day after intervention. Method of measurement: Computed tomography scan.;Coughing. Timepoint: 0 (before the start of the intervention) - 14th day after intervention. Method of measurement: Based on Visual Analogue Scale.;Complete blood count indices. Timepoint: 0 (before the intervention), 7th, 14th day after intervention. Method of measurement: Complete blood count test.

Secondary

MeasureTime frame
Duration of hospitalization. Timepoint: After the patient is discharged. Method of measurement: The number of days of hospitalization.;Body temperature. Timepoint: 0 (before the start of the intervention) - 14th day after intervention. Method of measurement: Thermometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSayyedeh Fatemeh Askari

Birjand University of Medical Sciences

sfaskari98@gmail.com+98 56 3238 1919

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026